Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Subjects”

484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 484 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04711824
What this trial is testing

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Who this might be right for
Breast CancerBrain Metastases, Adult
Colette Shen 41
Testing effectiveness (Phase 2)Study completedNCT00490646
What this trial is testing

A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
R-Pharm 50
Testing effectiveness (Phase 2)Ended earlyNCT02431260
What this trial is testing

An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 69
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Not applicableStudy completedNCT03676257
What this trial is testing

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

Who this might be right for
Metastatic Breast Cancer
Institut Bergonié 20,033
Testing effectiveness (Phase 2)Ended earlyNCT05091528
What this trial is testing

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

Who this might be right for
HER2-positive Breast CancerHER2-positive Gastric CancerHER2-positive Colorectal Cancer+1 more
Silverback Therapeutics 2
Early research (Phase 1)Active Not RecruitingNCT04042701
What this trial is testing

DS8201a and Pembrolizumab in Participants With Locally Advanced/Metastatic Breast or Non-Small Cell Lung Cancer

Who this might be right for
Breast CancerNon-small Cell Lung Carcinoma
Daiichi Sankyo 115
Testing effectiveness (Phase 2)Study completedNCT06188559
What this trial is testing

BB-1701 in Previously Treated Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive or HER2-low Unresectable or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Eisai Inc. 56
Early research (Phase 1)Study completedNCT04712396
What this trial is testing

Assess How Itraconazole Affects the Uptake and Elimination of Capivasertib in the Body

Who this might be right for
Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
AstraZeneca 11
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Large-scale testing (Phase 3)Ended earlyNCT00373113
What this trial is testing

A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine

Who this might be right for
Breast Neoplasms
Pfizer 482
Large-scale testing (Phase 3)Study completedNCT03556358
What this trial is testing

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer+2 more
Tanvex BioPharma USA, Inc. 809
Not applicableApproved For MarketingNCT00338247
What this trial is testing

EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis
Early research (Phase 1)Study completedNCT03810625
What this trial is testing

Food Effect Study of D-0502 Tablet in Healthy Volunteers

Who this might be right for
Breast Cancer
InventisBio Co., Ltd 14
Testing effectiveness (Phase 2)Ended earlyNCT02003092
What this trial is testing

RX-5902 Treatment of Subjects With Triple Negative Breast Cancer

Who this might be right for
Solid TumorTriple Negative Breast Cancer
Rexahn Pharmaceuticals, Inc. 18
Early research (Phase 1)Study completedNCT00366600
What this trial is testing

Study Evaluating HKI-272 Administered to Healthy Subjects

Who this might be right for
Healthy
Puma Biotechnology, Inc. 56
Testing effectiveness (Phase 2)Study completedNCT00398567
What this trial is testing

HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
Puma Biotechnology, Inc. 45
Early research (Phase 1)Study completedNCT00777530
What this trial is testing

Study Evaluating Ascending Single-Dose Of Bosutinib Administered With Multiple Doses Of Ketoconazole To Healthy Subjects

Who this might be right for
Breast CancerTumorsLeukemia
Wyeth is now a wholly owned subsidiary of Pfizer 48
Early research (Phase 1)Study completedNCT02307240
What this trial is testing

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Who this might be right for
Triple-Negative Breast CancerHigh-grade Serous Ovarian CancerSolid Tumors+1 more
Curis, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT01042925
What this trial is testing

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

Who this might be right for
Breast CancerBreast Neoplasms
Sanofi 42
Next Page